Impact of age and comorbidities on the efficacy and tolerability of bosutinib in previously treated patients with chronic myeloid leukemia: results from the phase 4 BYOND study

Rosti, Gianantonio; Hochhaus, Andreas; Gambacorti-Passerini, Carlo; Kuttschreuter, Luke; Giraldo-Castellano, Pilar; Zhao, Huadong; Castagnetti, Fausto; Giles, Francis J.; Ernst, Thomas; Purcell, Simon; Brümmendorf, Tim Henrik; Gjertsen, Björn T.

doi:10.18154/RWTH-CONV-252649

Mehr Informationen
Referenzen (0)
Diskussion (0)
Dateien

Impact of age and comorbidities on the efficacy and tolerability of bosutinib in previously treated patients with chronic myeloid leukemia: results from the phase 4 BYOND study - RWTH-CONV-252649

Ähnliche Datensätze

h1

h2

h3

h4

h5

h6

RWTH

Kontakt

RWTH Publications

Allgemeines